Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon beta-1b injections.
Mehta
C L
CL
University of Wisconsin Hospital and Clinics, Division of Dermatology, Madison, USA.
Tyler
R J
RJ
Cripps
D J
DJ
D000998:Antiviral Agents / Q000009:adverse effects*; D003872:Dermatitis / Q000150:complications / Q000209:etiology* / Q000473:pathology*; D006801:Humans; D007279:Injections, Subcutaneous; D016899:Interferon-beta / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000628:therapy; D011994:Recombinant Proteins / Q000009:adverse effects; D012507:Sarcoidosis / Q000139:chemically induced; D013577:Syndrome
D000998:Antiviral Agents; D011994:Recombinant Proteins; D016899:Interferon-beta